ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence (ART-CARMA)
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence ('ART-CARMA')
Sponsor: Attention Deficit Disorder Information and Support Service
A observational or N/A phase clinical study on Attention Deficit Hyperactivity Disorder and Cardiovascular Diseases, this trial is ongoing. The trial is conducted by Attention Deficit Disorder Information and Support Service and has accumulated 8 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Jun 2025 — Present [monthly]
Active Not Recruiting
-
Jan 2025 — Jun 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Mar 2023 — Nov 2023 [monthly]
Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Attention Deficit Disorder Information and Support Service
- Avon and Wiltshire Mental Health Partnership NHS Trust
- Barnet, Enfield and Haringey Mental Health NHS Trust
- Concentris research management gmbh
- East London NHS Foundation Trust
- Empatica, Inc.
- Hospital Universitari Vall d'Hebron Research Institute
- King's College London
- Northumberland, Tyne and Wear NHS Foundation Trust
- South London and Maudsley NHS Foundation Trust
- South West London and St George's Mental Health NHS Trust
- Tees, Esk and Wear Valleys NHS Foundation Trust
- The European Association for the Study of Obesity
- Örebro University, Sweden
For direct contact, visit the study record on ClinicalTrials.gov .